Short-course radiotherapy in elderly patients with glioblastoma: Feasibility and efficacy of results from a single centre

Strahlentherapie und Onkologie

Volumn 189, Issue 6, 2013, Pages 456-461

  Fariselli, L ^a   Pinzi, V ^a   Milanesi, I ^a   Silvani, A ^a   Marchetti, M ^a   Farinotti, M ^a   Salmaggi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Elderly; Glioblastoma; Hypofractionated; Radiation therapy

Indexed keywords

AGED; ARTICLE; BRAIN NECROSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HYPOFRACTIONATED ACCELERATED RADIOTHERAPY; MALE; MEDICAL RECORD REVIEW; NEUROLOGIC DISEASE; PROGRESSION FREE SURVIVAL; RADIATION DOSE;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84878300300     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0346-x     Document Type: Article

References (54)

1. American cancer society. Brain and spinal cord tumors in adults. http://www.cancer.org/cancer/braincnstumorsinadults/detailedguide/ brain-and-spinal-cord-tumors-in-adults (Online)
2. Brandes AA, Compostella A, Blatt V, Tosoni A (2006) Glioblastoma in the elderly: current and future trends. Crit Rev Oncol Hematol 60:256-266 (Pubitemid 44709622)
3. Brandes AA, Franceschi E, Tosoni A, et al. (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115:3512-3518
4. Brandes AA, Rigon A, Monfardini S (2000) Radiotherapy of the brain in elderly patients. Contra. Eur J Cancer 36:447-451 (Pubitemid 30136221)
5. Brandes AA, Vastola F, Basso U, et al. (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657-662 (Pubitemid 36125843)
6. Budach W, Gioioso D, Taghian A, et al. (1997) Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys 39:743-750 (Pubitemid 27441445)
7. Cao JQ, Fisher BJ, Bauman GS, et al. (2011) Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. J Neurooncol 107:395-405
8. Chang EL, Yi W, Allen PK, et al. (2003) Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 56:519-528 (Pubitemid 36542912)
9. Combs SE, Wagner J, Bischof M, et al. (2008) Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70:987-992 (Pubitemid 351296114)
10. Cooper-Kuhn CM, Kuhn HG (2002) Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res Dev Brain Res 134:13-21 (Pubitemid 34310233)
11. Curran WJ Jr, Scott CB, Horton J, et al. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710 (Pubitemid 23133591)
12. Filippini G, Falcone C, Boiardi A, et al. (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 10:79-87 (Pubitemid 351250903)
13. Gállego Pérez-Larraya J, Ducray F, Chinot O, et al. (2011) Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol 29:3050-3055
14. Gerstein J, Franz K, Steinbach JP, et al. (2011) Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution. Strahlenther Onkol 187:722-728
15. Grau JJ, Verger E (2000) Radiotherapy of the brain in elderly patients. Pro:. Eur J Cancer 36:443-447 (Pubitemid 30136220)
16. Greig NH, Ries LG, Yancik R, Rapoport SI (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82:1621-1624 (Pubitemid 20345298)
17. Guckenberger M, Mayer M, Buttmann M, et al. (2011) Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. Strahlenther Onkol 187:548-554
18. Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1997-2000. Cancer 101:2293-2299 (Pubitemid 39458686)
19. Hoegler DB, Davey P (1997) A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 33:201-204 (Pubitemid 27241308)
20. Hoffman S, Propp JM, McCarthy BJ (2006) Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 8:27-37 (Pubitemid 43154448)
21. Horiot JC, Bogaert W van de, Ang KK, et al. (1988) European organization for research on treatment of cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey. Front Radiat Ther Oncol 22:149-161
22. Idbaih A, Taillibert S, Simon JM, et al. (2008) Short course of radiation therapy in elderly patients with glioblastoma multiforme. Cancer Radiother 12:788-792
23. Iliadis G, Selviaridis P, Kalogera-Fountzila A, et al. (2009) The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized computer and geometric models. Strahlenther Onkol 185:743-750
24. International Commission on Radiation Units and Measurements (1993) Prescribing, recording and reporting photon beam therapy. Report 50, Bethesda, MD: ICRU
25. International Commission on Radiation Units and Measurements (1999) Prescribing, recording and reporting photon beam therapy. Report 62 (Supplement to ICRU Report 50) Bethesda, MD: ICRU
26. Iwamoto FM, Cooper AR, Reiner AS, et al. (2009) Glioblastoma in the elderly: the memorial Sloan-Kettering cancer center experience (1997-2007). Cancer 115:3758-3766
27. Iwamoto FM, Reiner AS, Panageas KS, et al. (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64:628-634
28. Levin VA, Maor MH, Thall PF, et al. (1995) Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 33:357-364
29. Keim H, Potthoff PC, Schmidt K, et al. (1987) Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiother Oncol 9:21-26 (Pubitemid 17121549)
30. Keime-Guibert F, Chinot O, Taillandier L, et al. (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535 (Pubitemid 46588417)
31. Kita D, Ciernik IF, Vaccarella S, et al. (2009) Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology 33:17-22
32. Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227-235 (Pubitemid 39136506)
33. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280 (Pubitemid 20195640)
34. Meckling S, Dold O, Forsyth PA, et al. (1996) Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47:901-905
35. Marijnen CA, Berg SM van den, Duinen SG van, et al. (2005) Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 75:210-216 (Pubitemid 40805252)
36. Minniti G, Lanzetta G, Scaringi C, et al. (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83:93-99
37. Mohan DS, Suh JH, Phan JL, et al. (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981-987 (Pubitemid 29004138)
38. Newall J, Ransohoff J, Kaplan B (1988) Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J Neurooncol 6:325-327 (Pubitemid 19032430)
39. Nieder C, Andratschke N, Wiedenmann N, et al. (2004) Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlenther Onkol 180:401-407 (Pubitemid 39207378)
40. Niyazi M, Schwarz SB, Suchorska B, Belka C (2012) Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Strahlenther Onkol 188:154-159
41. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002-6007
42. Pierga JY, Hoang-Xuan K, Feuvret L, et al. (1999) Treatment of malignant gliomas in the elderly. J Neurooncol 43:187-193 (Pubitemid 29445648)
43. Piroth MD, Pinkawa M, Holy R, et al. (2012) Integrate boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study. Strahlenther Onkol 188:334-339
44. Roa W, Brasher PM, Bauman G, et al. (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583-1588 (Pubitemid 41079795)
45. Scott CB, Scarantino C, Urtasun R, et al. (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:51-55 (Pubitemid 28027566)
46. Scott JC, Suh JH, Elson P, et al. (2011) Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 13:428-436
47. Scott JG, Bauchet L, Fraum TJ, et al. (2012) Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118:5595-5600
48. Simpson JR, Horton J, Scott C, et al. (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239-244 (Pubitemid 23156970)
49. Terasaki M, Eto T, Nakashima S, et al. (2011) A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. J Neurooncol 102:247-253
50. Vuorinen V, Hinkka S, Färkkilä M, Jaaskelainen J (2003) Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien) 145:5-10 (Pubitemid 36174074)
51. National cancer institute: cancer therapy evaluation program. http://ctep.cancer.gov/forms/ctcaev3.pdf. (Online)
52. Whittle IR, Basu N, Grant R, et al. (2002) Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Br J Neurosurg 16:343-347 (Pubitemid 35178578)
53. Whittle IR, Denholm SW, Gregor A (1991) Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. Surg Neurol 36:106-111
54. Zhang LY, Chen LS, Sun R, et al. (2012) Effects of expression level of DNA repair-related genes involved in the NHEJ pathway on radiation-induced cognitive impairment. J Radiat Res (Epub ahead of print)